Pharma News

Pfizer said it will expand its Kalamazoo, Mich., manufacturing facility to increase production of its COVID-19 drug Paxlovid (nirmatrelvir, ritonavir).

Eli Lilly’s home state of Indiana is set to benefit from a massive $2.1 billion investment by the pharma group, earmarked for two brand new manufacturing facilities. ...

AbbVie has reported new phase 3 data for its schizophrenia and bipolar disorder therapy Vraylar in treatment-resistant depression, as it waits for a decision by the FDA on the new indication. ...

Bavarian Nordic A/S (OMX: BAVA) announced today the signing of a supply contract with an undisclosed country for the Company’s smallpox vaccine with the aim to ensure sufficient supply to meet th...

Two big pharma companies are forging ahead with ulcerative colitis (UC) research after posting positive results from their respective Phase III studies.

Drug developer Shanghai Junshi Biosciences Co. Ltd. (1877.HK; 688180.SH) announced late Monday that VV116, an oral drug developed by its JunTop Biosciences unit for the early treatment of Covid-19,...

Approval for around 100 generics in Europe is to be suspended because a contract institute in India has worked poorly in the studies relevant to the approval of the drugs.

Pfizer has agreed to pay $290,000 to patients in Colorado, Vermont, Arizona and Kansas to settle allegations over alleged misleading copay coupons for four drugs. ...

SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, announced that the U.S. Food and Drug Administration (FDA) approved the int...

US scientists have begun a trial on a vaccine that will shield individuals from developing pancreatic cancer.

Pain and need for opiate painkillers among cancer patients may be reduced by medicinal cannabis as per a study published in Frontiers in Pain Research.

In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for mesothelioma after a patient death. Now, its partner Bayer has backed out of a partnership covering two ...